Neuroprotective effects of geniposide on Alzheimer’s disease pathology
Neuroprotective effects of geniposide on Alzheimer’s disease pathology
About this item
Full title
Author / Creator
Publisher
Germany: De Gruyter
Journal title
Language
English
Formats
Publication information
Publisher
Germany: De Gruyter
Subjects
More information
Scope and Contents
Contents
A growing body of evidence has linked two of the most common aged-related diseases: type 2 diabetes mellitus (T2DM) and Alzheimer’s disease (AD). It has led to the notion that drugs developed for the treatment of T2DM may be beneficial in modifying the pathophysiology of AD. As a receptor agonist of glucagon-like peptide-1 (GLP-1R), which is a newe...
Alternative Titles
Full title
Neuroprotective effects of geniposide on Alzheimer’s disease pathology
Authors, Artists and Contributors
Author / Creator
Identifiers
Primary Identifiers
Record Identifier
TN_cdi_proquest_miscellaneous_1722168303
Permalink
https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_proquest_miscellaneous_1722168303
Other Identifiers
ISSN
0334-1763
E-ISSN
2191-0200
DOI
10.1515/revneuro-2015-0005
